{"id":22617,"date":"2024-03-25T07:55:55","date_gmt":"2024-03-25T11:55:55","guid":{"rendered":"https:\/\/medicarereport.org\/?p=22617"},"modified":"2024-03-25T07:55:56","modified_gmt":"2024-03-25T11:55:56","slug":"fda-authorizes-new-drug-to-protect-immune-compromised-from-covid-19","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=22617","title":{"rendered":"FDA authorizes new drug to protect immune compromised from Covid-19"},"content":{"rendered":"\n<p>(By Jason Mast for ST<em>A<\/em>T)<\/p>\n\n\n\n<p>The Food and Drug Administration on Friday authorized a new antibody to protect immunocompromised individuals against Covid-19.<\/p>\n\n\n\n<p>The drug, known as Pemgarda and marketed by the biotech Invivyd, is the first such drug to become available since the agency pulled AstraZeneca\u2019s Evusheld off the market in January 2023. New Omicron variants had rendered Evusheld ineffective.  Continue reading <a href=\"https:\/\/www.statnews.com\/2024\/03\/22\/covid-immunocompromised-antibody-protection-invivyd\/\" data-type=\"link\" data-id=\"https:\/\/www.statnews.com\/2024\/03\/22\/covid-immunocompromised-antibody-protection-invivyd\/\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"250\" height=\"26\" class=\"wp-image-4372\" style=\"width: 250px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Jason Mast for STAT) The Food and Drug Administration on Friday authorized a new antibody to protect immunocompromised individuals<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,52],"tags":[1203,75,76,1201,1202],"class_list":["post-22617","post","type-post","status-publish","format-standard","hentry","category-fda","category-pandemic","tag-biotech-invivyd","tag-covid-19","tag-fda","tag-immune-compromised","tag-pemgarda"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22617"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22617\/revisions"}],"predecessor-version":[{"id":22618,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22617\/revisions\/22618"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}